These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9650527)
1. Do cholesterol-lowering drugs reduce stroke risk? Johns Hopkins Med Lett Health After 50; 1998 Jul; 10(5):8. PubMed ID: 9650527 [No Abstract] [Full Text] [Related]
3. Cholesterol-lowering therapy for primary prevention: still much we don't know. Green LA Arch Intern Med; 2010 Jun; 170(12):1007-8. PubMed ID: 20585062 [No Abstract] [Full Text] [Related]
4. Pravastatin for reducing stroke risk. Health News; 1999 Feb; 5(3):7. PubMed ID: 10081437 [No Abstract] [Full Text] [Related]
5. [Cholesterol reducing therapy--new aspects in stroke and diabetes]. Riesen WF Schweiz Med Wochenschr; 1998 Jan; 128(1-2):26-7. PubMed ID: 9491466 [No Abstract] [Full Text] [Related]
6. Cholesterol drugs: should you be taking one? Consum Rep; 1998 Oct; 63(10):54-5. PubMed ID: 10342966 [No Abstract] [Full Text] [Related]
7. Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial. Strandberg TE; Tilvis RS Lancet; 1997 Aug; 350(9075):442. PubMed ID: 9259675 [No Abstract] [Full Text] [Related]
8. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure]. Stalenhoef AF Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084 [TBL] [Abstract][Full Text] [Related]
9. Lipid lowering and recurrent stroke: another stroke paradox? Amarenco P Eur Heart J; 2005 Sep; 26(18):1818-9. PubMed ID: 16087646 [No Abstract] [Full Text] [Related]
10. [Anticholesteremic statins reduce myocardial infarction. Milestone studies give a straight answer--at least concerning the males]. Carlson LA Lakartidningen; 1999 Apr; 96(14):1725-8. PubMed ID: 10222689 [No Abstract] [Full Text] [Related]
11. [Lowering of cholesterol and the risk of stroke--new findings?]. Krankenpfl J; 1997; 35(7-8):289-92. PubMed ID: 9295598 [No Abstract] [Full Text] [Related]
12. [Statins: from hypocholesteremic drugs to antiatherogenic agents]. Manzoli A; Patti G; D'Ambrosio A; Montesanti R; Calabrese V; Abbate A; Gioia G; Di Sciascio G Clin Ter; 2001; 152(5):307-13. PubMed ID: 11794851 [TBL] [Abstract][Full Text] [Related]
13. [Cholesterol and stroke risk: a role for statins?]. Devuyst G; Bogousslavsky J Schweiz Med Wochenschr; 2000 Aug; 130(33):1157-63. PubMed ID: 11005106 [TBL] [Abstract][Full Text] [Related]
17. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?]. Müller-Wieland D; Faust M; Schleifenbaum T; Krone W MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015 [TBL] [Abstract][Full Text] [Related]
18. Treatment of high-risk older persons with lipid-lowering drug therapy. Aronow WS Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628 [TBL] [Abstract][Full Text] [Related]
19. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease. de Lau LM; Stricker BH; Breteler MM Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354 [No Abstract] [Full Text] [Related]
20. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]